Dudley & Shanley Inc. raised its position in Amdocs Limited (NASDAQ:DOX – Free Report) by 7.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 261,826 shares of the technology company’s stock after acquiring an additional 18,600 shares during the quarter. Amdocs makes up about 3.6% of Dudley & Shanley Inc.’s investment portfolio, making the stock its 15th largest holding. Dudley & Shanley Inc. owned 0.23% of Amdocs worth $22,905,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Private Trust Co. NA grew its position in shares of Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after purchasing an additional 117 shares in the last quarter. Brooklyn Investment Group acquired a new stake in Amdocs during the third quarter worth approximately $28,000. Catalyst Capital Advisors LLC acquired a new position in Amdocs in the 3rd quarter valued at $55,000. GAMMA Investing LLC lifted its position in shares of Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock valued at $70,000 after acquiring an additional 428 shares during the period. Finally, Meeder Asset Management Inc. bought a new position in shares of Amdocs in the third quarter worth $77,000. Institutional investors own 92.02% of the company’s stock.
Amdocs Stock Performance
NASDAQ DOX traded down $0.47 during trading on Monday, hitting $86.54. 675,091 shares of the company’s stock traded hands, compared to its average volume of 684,225. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.20. The stock has a market capitalization of $9.77 billion, a price-to-earnings ratio of 20.41, a PEG ratio of 1.45 and a beta of 0.72. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04. The business has a 50 day moving average of $87.93 and a 200-day moving average of $84.86.
Amdocs Announces Dividend
Analyst Upgrades and Downgrades
Several research firms recently weighed in on DOX. Stifel Nicolaus assumed coverage on Amdocs in a research note on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price objective on the stock. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 14th. Oppenheimer upped their price target on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, Barclays lowered their price objective on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Amdocs currently has an average rating of “Moderate Buy” and an average price target of $101.20.
View Our Latest Stock Report on Amdocs
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- What is a Special Dividend?
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.